COMMUNIQUÉS West-GlobeNewswire

ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections
14/08/2018
YONKERS, N.Y., Aug. 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
14/08/2018
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo” or the “Company”) announced the grant of inducement awards on August 14, 2018 to Dr. Steven G. Hughes, its new chief medical [...]
VistaGen Therapeutics Reports Fiscal 2019 First Quarter Financial Results
14/08/2018
SOUTH SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other [...]
Atrion Corporation Increases Quarterly Cash Dividend by 13%
14/08/2018
ALLEN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced an increase in its quarterly cash dividend from $1.20 per share to $1.35 per share. Specifically, the Board of Directors [...]
Mateon Therapeutics Reports Second Quarter 2018 Financial Results
14/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
14/08/2018
DUBLIN, Ireland and TREVOSE, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it intends to offer and sell 9,000,000 of its ordinary shares in an [...]
Mersana Therapeutics Announces Second Quarter 2018 Financial Results and Provides Business Updates
14/08/2018
Response to the FDA Partial Clinical Hold Submitted This Week Strong Balance Sheet with a cash position of $97M to close Q2 CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a [...]
Cytori Reports Q2 2018 Business and Financial Results
14/08/2018
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced Q2 2018 financial results and provided updates on corporate activities. Q2 2018 net loss was $3 [...]
Akers Biosciences Announces Q2 and H1 2018 Earnings
14/08/2018
THOROFARE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results [...]
The Cooper Companies to Participate in the Wells Fargo Securities Healthcare Conference
14/08/2018
PLEASANTON, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will participate in the 2018 Wells Fargo Securities Healthcare Conference in Boston, MA, on September 6, 2018. Albert G. White [...]
Precision Therapeutics Reports Second Quarter 2018 Financial Results
14/08/2018
Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end of 2018 MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “ [...]
Acura Pharmaceuticals Announces Second Quarter 2018 Financial Results
14/08/2018
PALATINE, Ill., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six [...]
Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Progress
14/08/2018
LOS ANGELES, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]
Oncobiologics Provides Business Update and Reports Third Quarter Financial Results for Fiscal 2018
14/08/2018
CRANBURY, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS) today reported financial results and business highlights for its three and nine months ended June 30, 2018. Recent Highlights: [...]
Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results
14/08/2018
Company raises an aggregate of $160 million in crossover financing in April and initial public offering (IPO) in July Company progressing its pipeline, including clinical programs CPI-1205 and CPI-0610 CAMBRIDGE, Mass [...]
Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures
14/08/2018
SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a [...]
Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results for its fiscal third quarter [...]
iKang Announces Further Update on “Going Private” Transaction
14/08/2018
BEIJING, Aug. 14, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
MRI Interventions Reports Second Quarter Results
14/08/2018
Biologics Trials, CE Mark Clearances and FDA Submissions Expand Market Opportunities IRVINE, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial [...]

Pages